Liver fibrosis
Conditions
Interventions
Western medicine control group:Entecavir Tablets
treatment group:Qi Jia Rou Gan Fang+ Entecavir Tablets
Healthy control group:no
Sponsors
Chengdu Public Health Clinical Medical Center
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Meet the diagnostic criteria of chronic hepatitis B liver fibrosis;2.Meet the diagnostic criteria of Chinese medicine qi deficiency and collateral blockage; 3.Age between 18-70 years old; 4. Good compliance and signing the informed consent.
Exclusion criteria
Exclusion criteria: 1.those who do not meet the inclusion criteria;2. those with poor compliance;3. those who are participating in other research projects;4.those who are diagnosed with chronic hepatitis B of severe type or have a tendency to severe hepatitis etc.;5.those with other types of hepatitis such as alcoholic drug-induced and other viral liver diseases;6. those with posthepatitis decompensated stage;7. those who suffer from combined serious heart brain lung and kidney diseases or tumors;8.pregnant or lactating women;9. those who suffer from mental diseases or are incapable of cooperation. Those who are mentally ill or unable to cooperate.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| transient elastography;AFP;Liver function;Serum proteomic indicators;Objectify tongue pulse and eye information;Serum liver fibrosis indicators;echocardiography; | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood clotting time; | — |
Countries
China
Contacts
Public ContactLi Jike
Chengdu Public Health Clinical Medical Center
Outcome results
None listed